by Shi-qi An | May 26, 2026 | News
Abselion has contributed to a new editorial in Drug Discovery & Development, developed in collaboration with the VIB Protein Core Facility. The article brings together core facility experience and technology development perspectives, exploring how protein...
by Shi-qi An | May 15, 2026 | News
We’re pleased to share a new interview with Dr Ruizhi Wang, CEO of Abselion, conducted by The Medicine Maker’s editorial team. In this conversation, Ruizhi reflects on how engineering principles can help make sense of biological complexity and why thoughtful...
by Shi-qi An | May 7, 2026 | News
Abselion has received the Best Antibody Discovery Platform 2026 – UK award in the GHP Biotechnology & Lifesciences Awards 2026, recognising the work behind the Amperia™ platform. Amperia™ supports faster, simpler biologics quantification across research and...
by Shi-qi An | May 6, 2026 | News
Abselion contributes to AZoNetwork’s latest Industry Focus eBook, highlighting practical approaches to protein quantification using the Amperia™ platform. Abselion has been featured in the latest Industry Focus: Protein Analysis eBook published by AZoNetwork. The...
by Shi-qi An | Apr 13, 2026 | News
BioTechniques recently featured an interview with Dale Gordon, who recently joined Abselion as Chair of the Board, exploring what it takes for life science technologies to move from innovation into practical, real-world use. Drawing on leadership experience across...
by Shi-qi An | Feb 5, 2026 | News
Abselion’s VP of Science, Paolo Romele, has contributed to a multi-contributor editorial published by BioCompare, exploring the role of cell line selection in therapeutic antibody production. The article brings together perspectives from across the bioprocessing...
